128 related articles for article (PubMed ID: 21993862)
21. Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India.
Ateeq B; Kunju LP; Carskadon SL; Pandey SK; Singh G; Pradeep I; Tandon V; Singhai A; Goel A; Amit S; Agarwal A; Dinda AK; Seth A; Tsodikov A; Chinnaiyan AM; Palanisamy N
Prostate; 2015 Jul; 75(10):1051-62. PubMed ID: 25809148
[TBL] [Abstract][Full Text] [Related]
22. SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.
Cheng XH; Black M; Ustiyan V; Le T; Fulford L; Sridharan A; Medvedovic M; Kalinichenko VV; Whitsett JA; Kalin TV
PLoS Genet; 2014 Sep; 10(9):e1004656. PubMed ID: 25254494
[TBL] [Abstract][Full Text] [Related]
23. Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.
Lunardi A; Varmeh S; Chen M; Taulli R; Guarnerio J; Ala U; Seitzer N; Ishikawa T; Carver BS; Hobbs RM; Quarantotti V; Ng C; Berger AH; Nardella C; Poliseno L; Montironi R; Castillo-Martin M; Cordon-Cardo C; Signoretti S; Pandolfi PP
Cancer Discov; 2015 May; 5(5):550-63. PubMed ID: 25653093
[TBL] [Abstract][Full Text] [Related]
24. Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate.
John K; Ragavan N; Pratt MM; Singh PB; Al-Buheissi S; Matanhelia SS; Phillips DH; Poirier MC; Martin FL
Prostate; 2009 Apr; 69(5):505-19. PubMed ID: 19143007
[TBL] [Abstract][Full Text] [Related]
25. Stem cells and the role of ETS transcription factors in the differentiation hierarchy of normal and malignant prostate epithelium.
Archer LK; Frame FM; Maitland NJ
J Steroid Biochem Mol Biol; 2017 Feb; 166():68-83. PubMed ID: 27185499
[TBL] [Abstract][Full Text] [Related]
26. ERG upregulation and related ETS transcription factors in prostate cancer.
Rostad K; Mannelqvist M; Halvorsen OJ; Oyan AM; Bø TH; Stordrange L; Olsen S; Haukaas SA; Lin B; Hood L; Jonassen I; Akslen LA; Kalland KH
Int J Oncol; 2007 Jan; 30(1):19-32. PubMed ID: 17143509
[TBL] [Abstract][Full Text] [Related]
27. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
Rickman DS; Pflueger D; Moss B; VanDoren VE; Chen CX; de la Taille A; Kuefer R; Tewari AK; Setlur SR; Demichelis F; Rubin MA
Cancer Res; 2009 Apr; 69(7):2734-8. PubMed ID: 19293179
[TBL] [Abstract][Full Text] [Related]
28. Signatures of prostate-derived Ets factor (PDEF) in cancer.
Mahajan N
Tumour Biol; 2016 Nov; 37(11):14335-14340. PubMed ID: 27612480
[TBL] [Abstract][Full Text] [Related]
29. PDEF in prostate cancer.
Sood AK; Kim H; Geradts J
Prostate; 2012 May; 72(6):592-6. PubMed ID: 21796651
[TBL] [Abstract][Full Text] [Related]
30. Effects of age, sex steroids, and family relationships on volumes of prostate zones in men with and without prostate cancer.
Meikle AW; Stephenson RA; McWhorter WP; Skolnick MH; Middleton RG
Prostate; 1995 May; 26(5):253-9. PubMed ID: 7753710
[TBL] [Abstract][Full Text] [Related]
31. ETS gene fusions in prostate cancer.
Clark JP; Cooper CS
Nat Rev Urol; 2009 Aug; 6(8):429-39. PubMed ID: 19657377
[TBL] [Abstract][Full Text] [Related]
32. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
Sakai I; Harada K; Kurahashi T; Yamanaka K; Hara I; Miyake H
Int J Urol; 2006 Apr; 13(4):368-72. PubMed ID: 16734852
[TBL] [Abstract][Full Text] [Related]
33. TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.
Iljin K; Wolf M; Edgren H; Gupta S; Kilpinen S; Skotheim RI; Peltola M; Smit F; Verhaegh G; Schalken J; Nees M; Kallioniemi O
Cancer Res; 2006 Nov; 66(21):10242-6. PubMed ID: 17079440
[TBL] [Abstract][Full Text] [Related]
34. Androgen regulation of ETS gene fusion transcripts in prostate cancer.
Gasi D; Trapman J
Methods Mol Biol; 2011; 776():335-48. PubMed ID: 21796535
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic ETS Factors in Prostate Cancer.
Nicholas TR; Strittmatter BG; Hollenhorst PC
Adv Exp Med Biol; 2019; 1210():409-436. PubMed ID: 31900919
[TBL] [Abstract][Full Text] [Related]
36. ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression.
Longoni N; Sarti M; Albino D; Civenni G; Malek A; Ortelli E; Pinton S; Mello-Grand M; Ostano P; D'Ambrosio G; Sessa F; Garcia-Escudero R; Thalmann GN; Chiorino G; Catapano CV; Carbone GM
Cancer Res; 2013 Jul; 73(14):4533-47. PubMed ID: 23687337
[TBL] [Abstract][Full Text] [Related]
37. In Vivo Quantification of Water Diffusion, Stiffness, and Tissue Fluidity in Benign Prostatic Hyperplasia and Prostate Cancer.
Asbach P; Ro SR; Aldoj N; Snellings J; Reiter R; Lenk J; Köhlitz T; Haas M; Guo J; Hamm B; Braun J; Sack I
Invest Radiol; 2020 Aug; 55(8):524-530. PubMed ID: 32496317
[TBL] [Abstract][Full Text] [Related]
38. Triexponential function analysis of diffusion-weighted MRI for diagnosing prostate cancer.
Ueda Y; Takahashi S; Ohno N; Kyotani K; Kawamitu H; Miyati T; Aoyama N; Ueno Y; Kitajima K; Kawakami F; Okuaki T; Tsukamoto R; Yanagita E; Sugimura K
J Magn Reson Imaging; 2016 Jan; 43(1):138-48. PubMed ID: 26119033
[TBL] [Abstract][Full Text] [Related]
39. [Expression of different genes in transitional zone and peripheral zone of human normal prostate].
Sun HB; Xia SJ; Tang XD
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):610-3. PubMed ID: 15949358
[TBL] [Abstract][Full Text] [Related]
40. Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.
Gregg JL; Brown KE; Mintz EM; Piontkivska H; Fraizer GC
BMC Cancer; 2010 Apr; 10():165. PubMed ID: 20426842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
